Table 1 Available studies investigating mobile health in male patients suffering from lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

From: Mobile health: a promising tool for the management of male patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Study

Country

App

Sample size (n)

Age, yr Mean (SD)

Main findings

Limitations acknowledged by authors

Kim, 2014 [3]

Korea

Smartphone version of the IPSS

1581

58.4 (7.2)

No differences between the paper and the smartphone versions of the IPSS in terms of total score and each item of the IPSS score across all LUTS severity groups.

Feasibility: 48.0% stated that the smartphone version was more feasible, 26.5% stated that the paper version was more feasible, and 19.0% stated that both of the versions were feasible.

Preference: 51.8% preferred the smartphone version, 20.2% preferred the paper version, and 22.5% showed no preference.

Only participants who had smartphones could participate.

Morselli, 2020 [4]

Italy

MyBPHCare (Ydeal, Portugal)

24

60 (55–64)°

Compliance: 95% within the first 45 days.

58.3% of patients requested clarifications/info via messenger.

All patients expressed their satisfaction after one month.

Small sample size.

No control group and mid-term follow up.

Lee, 2021[5]

USA

PERSONAL

19

70 (7)

On a scale from 1 (strongly disagree) to 5 (strongly agree), the participants agreed that:

- the app was easy to use (4.3 ± 1.0)

- they could imagine people learning to use it quickly (4.2 ± 0.9)

- they felt confident using the app (4.4 ± 0.8)

58% of the participants reported that the app could help people like them manage their urinary symptoms

Black or African American participants not recruited.

Inclusion of highly educated participants with a high socioeconomic status.

Use of detailed baseline and follow-up questionnaires.

Wang, 2021 [6]

USA

PERSONAL

19

70 (7)

9 patients felt that the app changed their perception of their health or LUTS management: 8 reported increased awareness of symptoms and 1 was able to adjust his fluid intake to improve LUTS.

Need for less structured interviews in more diverse patient populations.

Liu, 2022 [7]

China

EPSS

79

70.4 (6.6)

Full-understanding rates in patients aged >70 and < 70 years were 50% and 64.1%, respectively (p = 0.206).

Significant correlation between EPSS, VPSS and assessment by urology specialists.

Some relevant clinical data were not present (ongoing medical treatments, comorbidities, urine flow rates, and postvoiding residuals).

Patients were not divided between first-visit and follow-up group.

Kim, 2022 [8]

Korea

Healthy Bladder-VD (Soundable Health, Inc.)

78

55 (40–65)°

Higher scores in the convenience and satisfaction area were reported by patients using the mobile app VD compared to those using the paper-based VD.

Overall preference for using the mobile app instead of the paper-based VD: 9 out of 10 (7.82 ± 2.68).

Good correlation between the two methods for nocturnal urine volume, nocturnal polyuria index, total number of voids, number of nocturnal voids, and maximal bladder capacity.

Background noise.

  1. App Application, BPH Benign Prostatic Hyperplasia, EPSS Electronic Version of VPSS, IPSS International Prostate Symptom Score, LUTS Lower Urinary Tract Symptoms, PC Personal Computer, PERSONAL Placebo–Controlled, Randomized, Patient-Selected Outcomes, N-of-1 Trials, SD Standard Deviation, VD Voiding Diary, VPSS Visual Prostate Symptom Score, °Median (range).